DESCRIPTION
A 22-year-old woman was referred for management of intermittent haemoptysis. She had been diagnosed with hereditary haemorrhagic telangiectasia (HHT) when she was 5 years old and had undergone coil embolisation for treatment of pulmonary arteriovenous malformation (PAVM) at the ages of 6, 11 and 21 years. CT of the chest revealed multiple areas of PAVM and enhanced consolidation confined to the left lower lobe, and a large PAVM in the area that was previously coiled (figure 1). Pulmonary arteriogram was demonstrated (figures 2 and 3). There was no active site of contrast leaking, thus the patient was vigilantly monitored in the intensive care unit. However, she continued to experience intermittent haemoptysis. In the absence of randomised controlled trials for most of the available treatments for PAVM, the patient underwent a left partial lobectomy to prevent lifethreatening complications such as massive haemoptysis, brain abscess, paradoxical embolism and ischaemic stroke.
The persistent pattern, defined as continuous perfusion of the PAVM, is demonstrated by Figure 1 CT of the chest demonstrating multiple bilateral pulmonary arteriovenous malformation (PAVM). Note an area of enhanced consolidation (blue arrow), a large PAVM (green arrow) and evidence of previous coiling attempts confined to the left lower lobe (red arrow). 
2 pulmonary-to-pulmonary reperfusion 2 and rare systemic-to-pulmonary reperfusion. 3 Recanalisation is the most common persistence pattern of simple PAVM, and is associated with a high success rate after re-treatment with embolisation. 1 We highlight an uncommon persistent pattern attributed to recanalisation of the two feeding arteries and a segmental artery that were previously coiled, forming a large complex PAVM. Surgical excision is the treatment of choice for patients with symptomatic PAVM in HHT (Osler-Weber-Rendu syndrome) who fail multiple treatments with coil embolisation in 15 years follow-up.
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